These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32945387)

  • 1. Downregulated Mucin 1 alleviates paclitaxel resistance in non‑small cell lung cancer cells.
    Xu H; Gao H; Li H; Li D; Yuan W; Zhang L; Cheng P; Su X; Li Z; Wang G; Zhang T
    Mol Med Rep; 2020 Oct; 22(4):2966-2972. PubMed ID: 32945387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of miR-4262 in paclitaxel resistance through the regulation of PTEN in non-small cell lung cancer.
    Sun H; Zhou X; Bao Y; Xiong G; Cui Y; Zhou H
    Open Biol; 2019 Jul; 9(7):180227. PubMed ID: 31337279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL21/CCR7 prevents apoptosis via the ERK pathway in human non-small cell lung cancer cells.
    Xu Y; Liu L; Qiu X; Liu Z; Li H; Li Z; Luo W; Wang E
    PLoS One; 2012; 7(3):e33262. PubMed ID: 22438908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNHG7 mediates cisplatin-resistance in non-small cell lung cancer by activating PI3K/AKT pathway.
    Chen K; Abuduwufuer A; Zhang H; Luo L; Suotesiyali M; Zou Y
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6935-6943. PubMed ID: 31486493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-30a-5p enhances paclitaxel sensitivity in non-small cell lung cancer through targeting BCL-2 expression.
    Xu X; Jin S; Ma Y; Fan Z; Yan Z; Li W; Song Q; You W; Lyu Z; Song Y; Shi P; Liu Y; Han X; Li L; Li Y; Liu Y; Ye Q
    J Mol Med (Berl); 2017 Aug; 95(8):861-871. PubMed ID: 28487996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non‑coding RNA AK001796 contributes to cisplatin resistance of non‑small cell lung cancer.
    Liu B; Pan CF; Ma T; Wang J; Yao GL; Wei K; Chen YJ
    Mol Med Rep; 2017 Oct; 16(4):4107-4112. PubMed ID: 29067469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paris saponin I induces apoptosis via increasing the Bax/Bcl-2 ratio and caspase-3 expression in gefitinib-resistant non-small cell lung cancer in vitro and in vivo.
    Jiang H; Zhao PJ; Su D; Feng J; Ma SL
    Mol Med Rep; 2014 Jun; 9(6):2265-72. PubMed ID: 24718383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.
    Li C; Zhao X; Yang Y; Liu S; Liu Y; Li X
    Med Sci Monit; 2018 May; 24():2750-2757. PubMed ID: 29723165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of miR‑935 increases paclitaxel sensitivity via regulation of SOX7 in non‑small‑cell lung cancer.
    Peng B; Li C; Cai P; Yu L; Zhao B; Chen G
    Mol Med Rep; 2018 Sep; 18(3):3397-3402. PubMed ID: 30066948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel.
    Yu H; Xu Z; Chen X; Xu L; Yin Q; Zhang Z; Li Y
    Macromol Biosci; 2014 Jan; 14(1):100-9. PubMed ID: 23966347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of paederosidic acid in human non-small cell lung cancer cells via inducing mitochondria-mediated apoptosis.
    Yu P; Shi L; Song M; Meng Y
    Chem Biol Interact; 2017 May; 269():33-40. PubMed ID: 28185768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting apoptosis by 1,2-diazole through regulation of EGFR, Bcl-2 and CDK-2 mediated signaling pathway in human non-small cell lung carcinoma A549 cells.
    Vinod Prabhu V; Elangovan P; Niranjali Devaraj S; Sakthivel KM
    Gene; 2018 Dec; 679():352-359. PubMed ID: 30218747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation/paclitaxel treatment of p53-abnormal non-small cell lung cancer xenograft tumor and associated mechanism.
    Li G; Zhao J; Peng X; Liang J; Deng X; Chen Y
    Cancer Biother Radiopharm; 2012 May; 27(4):227-33. PubMed ID: 22489661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of ephrin receptor A7 suppresses the proliferation and metastasis of A549 human lung cancer cells.
    Li R; Sun Y; Jiang A; Wu Y; Li C; Jin M; Yan H; Jin H
    Mol Med Rep; 2016 Apr; 13(4):3190-6. PubMed ID: 26936314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
    Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J
    Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNAi targeting STMN alleviates the resistance to taxol and collectively contributes to down regulate the malignancy of NSCLC cells in vitro and in vivo.
    Long D; Yu T; Chen X; Liao Y; Lin X
    Cell Biol Toxicol; 2018 Feb; 34(1):7-21. PubMed ID: 28589243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA‑92a promotes non‑small cell lung cancer cell growth by targeting tumor suppressor gene FBXW7.
    Ni D; Teng J; Cheng Y; Zhu Z; Zhuang B; Yang Z
    Mol Med Rep; 2020 Oct; 22(4):2817-2825. PubMed ID: 32945381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
    Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
    Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-339-5p downregulation contributes to Taxol resistance in small-cell lung cancer by targeting α1,2-fucosyltransferase 1.
    Gan CZ; Li G; Luo QS; Li HM
    IUBMB Life; 2017 Nov; 69(11):841-849. PubMed ID: 28940895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing of a monoamine oxidase A inhibitor‑heptamethine carbocyanine dye conjugate for paclitaxel‑resistant non‑small cell lung cancer.
    Yang XG; Li YY; Zhao DX; Cui W; Li H; Li XY; Li YX; Wang D
    Oncol Rep; 2021 Mar; 45(3):1306-1314. PubMed ID: 33650669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.